nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Convulsion—Everolimus—kidney cancer	0.00241	0.00241	CcSEcCtD
Cefoxitin—Erythema multiforme—Dactinomycin—kidney cancer	0.00239	0.00239	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00236	0.00236	CcSEcCtD
Cefoxitin—Haemolytic anaemia—Capecitabine—kidney cancer	0.00235	0.00235	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Pazopanib—kidney cancer	0.00235	0.00235	CcSEcCtD
Cefoxitin—Flushing—Dactinomycin—kidney cancer	0.00234	0.00234	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00233	0.00233	CcSEcCtD
Cefoxitin—Erythema—Sunitinib—kidney cancer	0.00232	0.00232	CcSEcCtD
Cefoxitin—Renal failure acute—Capecitabine—kidney cancer	0.0023	0.0023	CcSEcCtD
Cefoxitin—Abdominal pain—Pazopanib—kidney cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00225	0.00225	CcSEcCtD
Cefoxitin—Hypersensitivity—Temsirolimus—kidney cancer	0.00225	0.00225	CcSEcCtD
Cefoxitin—Anaemia—Sorafenib—kidney cancer	0.00223	0.00223	CcSEcCtD
Cefoxitin—Thrombocytopenia—Vinblastine—kidney cancer	0.00223	0.00223	CcSEcCtD
Cefoxitin—Urinary tract disorder—Vincristine—kidney cancer	0.00223	0.00223	CcSEcCtD
Cefoxitin—Agranulocytosis—Gemcitabine—kidney cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Thrombocytopenia—Everolimus—kidney cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Urethral disorder—Vincristine—kidney cancer	0.00221	0.00221	CcSEcCtD
Cefoxitin—Angioedema—Sorafenib—kidney cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Erythema—Dactinomycin—kidney cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Leukopenia—Sorafenib—kidney cancer	0.00216	0.00216	CcSEcCtD
Cefoxitin—Pruritus—Temsirolimus—kidney cancer	0.00216	0.00216	CcSEcCtD
Cefoxitin—Haemoglobin—Gemcitabine—kidney cancer	0.00215	0.00215	CcSEcCtD
Cefoxitin—Anaemia—Sunitinib—kidney cancer	0.00215	0.00215	CcSEcCtD
Cefoxitin—Thrombocytopenia—Erlotinib—kidney cancer	0.00214	0.00214	CcSEcCtD
Cefoxitin—Haemorrhage—Gemcitabine—kidney cancer	0.00214	0.00214	CcSEcCtD
Cefoxitin—Pancytopenia—Paclitaxel—kidney cancer	0.00213	0.00213	CcSEcCtD
Cefoxitin—Angioedema—Sunitinib—kidney cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Hypotension—Everolimus—kidney cancer	0.00212	0.00212	CcSEcCtD
Cefoxitin—Urinary tract disorder—Gemcitabine—kidney cancer	0.00211	0.00211	CcSEcCtD
Cefoxitin—Urethral disorder—Gemcitabine—kidney cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Neutropenia—Paclitaxel—kidney cancer	0.00209	0.00209	CcSEcCtD
Cefoxitin—Diarrhoea—Temsirolimus—kidney cancer	0.00209	0.00209	CcSEcCtD
Cefoxitin—Leukopenia—Sunitinib—kidney cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Pruritus—Pazopanib—kidney cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Anaemia—Dactinomycin—kidney cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Erythema multiforme—Gemcitabine—kidney cancer	0.00202	0.00202	CcSEcCtD
Cefoxitin—Dyspnoea—Everolimus—kidney cancer	0.00202	0.00202	CcSEcCtD
Cefoxitin—Convulsion—Sunitinib—kidney cancer	0.00201	0.00201	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Doxorubicin—kidney cancer	0.002	0.002	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00198	0.00198	CcSEcCtD
Cefoxitin—Anaphylactic shock—Sorafenib—kidney cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Leukopenia—Dactinomycin—kidney cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Diarrhoea—Pazopanib—kidney cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Dyspnoea—Erlotinib—kidney cancer	0.00195	0.00195	CcSEcCtD
Cefoxitin—Pain—Vinblastine—kidney cancer	0.00195	0.00195	CcSEcCtD
Cefoxitin—Pain—Everolimus—kidney cancer	0.00194	0.00194	CcSEcCtD
Cefoxitin—Vomiting—Temsirolimus—kidney cancer	0.00194	0.00194	CcSEcCtD
Cefoxitin—Thrombocytopenia—Sorafenib—kidney cancer	0.00193	0.00193	CcSEcCtD
Cefoxitin—Rash—Temsirolimus—kidney cancer	0.00192	0.00192	CcSEcCtD
Cefoxitin—Dermatitis—Temsirolimus—kidney cancer	0.00192	0.00192	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00191	0.00191	CcSEcCtD
Cefoxitin—Vaginal inflammation—Doxorubicin—kidney cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Pain—Erlotinib—kidney cancer	0.00187	0.00187	CcSEcCtD
Cefoxitin—Erythema—Gemcitabine—kidney cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Vinblastine—kidney cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Thrombocytopenia—Sunitinib—kidney cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Everolimus—kidney cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Vomiting—Pazopanib—kidney cancer	0.00183	0.00183	CcSEcCtD
Cefoxitin—Anaemia—Vincristine—kidney cancer	0.00182	0.00182	CcSEcCtD
Cefoxitin—Colitis—Doxorubicin—kidney cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Rash—Pazopanib—kidney cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Nausea—Temsirolimus—kidney cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Dermatitis—Pazopanib—kidney cancer	0.00181	0.00181	CcSEcCtD
Cefoxitin—Candida infection—Doxorubicin—kidney cancer	0.0018	0.0018	CcSEcCtD
Cefoxitin—Haemoglobin—Paclitaxel—kidney cancer	0.0018	0.0018	CcSEcCtD
Cefoxitin—Abdominal pain—Vinblastine—kidney cancer	0.0018	0.0018	CcSEcCtD
Cefoxitin—Abdominal pain—Everolimus—kidney cancer	0.00179	0.00179	CcSEcCtD
Cefoxitin—Body temperature increased—Everolimus—kidney cancer	0.00179	0.00179	CcSEcCtD
Cefoxitin—Haemorrhage—Paclitaxel—kidney cancer	0.00179	0.00179	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Erlotinib—kidney cancer	0.00179	0.00179	CcSEcCtD
Cefoxitin—Vaginal infection—Doxorubicin—kidney cancer	0.00178	0.00178	CcSEcCtD
Cefoxitin—Aplastic anaemia—Doxorubicin—kidney cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Urinary tract disorder—Paclitaxel—kidney cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Leukopenia—Vincristine—kidney cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Urethral disorder—Paclitaxel—kidney cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Thrombocytopenia—Dactinomycin—kidney cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Dyspnoea—Sorafenib—kidney cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Pancytopenia—Capecitabine—kidney cancer	0.00174	0.00174	CcSEcCtD
Cefoxitin—Abdominal pain—Erlotinib—kidney cancer	0.00173	0.00173	CcSEcCtD
Cefoxitin—Body temperature increased—Erlotinib—kidney cancer	0.00173	0.00173	CcSEcCtD
Cefoxitin—Anaemia—Gemcitabine—kidney cancer	0.00172	0.00172	CcSEcCtD
Cefoxitin—Neutropenia—Capecitabine—kidney cancer	0.00172	0.00172	CcSEcCtD
Cefoxitin—Rash maculo-papular—Doxorubicin—kidney cancer	0.00172	0.00172	CcSEcCtD
Cefoxitin—Nausea—Pazopanib—kidney cancer	0.00171	0.00171	CcSEcCtD
Cefoxitin—Convulsion—Vincristine—kidney cancer	0.0017	0.0017	CcSEcCtD
Cefoxitin—Erythema multiforme—Paclitaxel—kidney cancer	0.00169	0.00169	CcSEcCtD
Cefoxitin—Dyspnoea—Sunitinib—kidney cancer	0.00169	0.00169	CcSEcCtD
Cefoxitin—Pain—Sorafenib—kidney cancer	0.00168	0.00168	CcSEcCtD
Cefoxitin—Hypersensitivity—Vinblastine—kidney cancer	0.00168	0.00168	CcSEcCtD
Cefoxitin—Hypersensitivity—Everolimus—kidney cancer	0.00167	0.00167	CcSEcCtD
Cefoxitin—Leukopenia—Gemcitabine—kidney cancer	0.00167	0.00167	CcSEcCtD
Cefoxitin—Flushing—Paclitaxel—kidney cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00162	0.00162	CcSEcCtD
Cefoxitin—Pain—Sunitinib—kidney cancer	0.00162	0.00162	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Sorafenib—kidney cancer	0.00161	0.00161	CcSEcCtD
Cefoxitin—Pruritus—Everolimus—kidney cancer	0.00161	0.00161	CcSEcCtD
Cefoxitin—Anaphylactic shock—Vincristine—kidney cancer	0.0016	0.0016	CcSEcCtD
Cefoxitin—Jaundice—Capecitabine—kidney cancer	0.0016	0.0016	CcSEcCtD
Cefoxitin—Phlebitis—Doxorubicin—kidney cancer	0.00159	0.00159	CcSEcCtD
Cefoxitin—Thrombophlebitis—Doxorubicin—kidney cancer	0.00158	0.00158	CcSEcCtD
Cefoxitin—Thrombocytopenia—Vincristine—kidney cancer	0.00157	0.00157	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Doxorubicin—kidney cancer	0.00157	0.00157	CcSEcCtD
Cefoxitin—Urticaria—Sorafenib—kidney cancer	0.00156	0.00156	CcSEcCtD
Cefoxitin—Erythema—Paclitaxel—kidney cancer	0.00156	0.00156	CcSEcCtD
Cefoxitin—Diarrhoea—Vinblastine—kidney cancer	0.00156	0.00156	CcSEcCtD
Cefoxitin—Body temperature increased—Sorafenib—kidney cancer	0.00156	0.00156	CcSEcCtD
Cefoxitin—Abdominal pain—Sorafenib—kidney cancer	0.00156	0.00156	CcSEcCtD
Cefoxitin—Diarrhoea—Everolimus—kidney cancer	0.00155	0.00155	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Sunitinib—kidney cancer	0.00155	0.00155	CcSEcCtD
Cefoxitin—Pruritus—Erlotinib—kidney cancer	0.00155	0.00155	CcSEcCtD
Cefoxitin—Pain—Dactinomycin—kidney cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Agranulocytosis—Capecitabine—kidney cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Anaphylactic shock—Gemcitabine—kidney cancer	0.00152	0.00152	CcSEcCtD
Cefoxitin—Body temperature increased—Sunitinib—kidney cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Abdominal pain—Sunitinib—kidney cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Diarrhoea—Erlotinib—kidney cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Hypotension—Vincristine—kidney cancer	0.0015	0.0015	CcSEcCtD
Cefoxitin—Thrombocytopenia—Gemcitabine—kidney cancer	0.00149	0.00149	CcSEcCtD
Cefoxitin—Renal failure acute—Doxorubicin—kidney cancer	0.00148	0.00148	CcSEcCtD
Cefoxitin—Haemoglobin—Capecitabine—kidney cancer	0.00148	0.00148	CcSEcCtD
Cefoxitin—Haemorrhage—Capecitabine—kidney cancer	0.00147	0.00147	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00147	0.00147	CcSEcCtD
Cefoxitin—Urinary tract disorder—Capecitabine—kidney cancer	0.00145	0.00145	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00145	0.00145	CcSEcCtD
Cefoxitin—Hypersensitivity—Sorafenib—kidney cancer	0.00145	0.00145	CcSEcCtD
Cefoxitin—Vomiting—Vinblastine—kidney cancer	0.00145	0.00145	CcSEcCtD
Cefoxitin—Vomiting—Everolimus—kidney cancer	0.00144	0.00144	CcSEcCtD
Cefoxitin—Anaemia—Paclitaxel—kidney cancer	0.00144	0.00144	CcSEcCtD
Cefoxitin—Urethral disorder—Capecitabine—kidney cancer	0.00144	0.00144	CcSEcCtD
Cefoxitin—Rash—Everolimus—kidney cancer	0.00143	0.00143	CcSEcCtD
Cefoxitin—Dermatitis—Everolimus—kidney cancer	0.00143	0.00143	CcSEcCtD
Cefoxitin—Angioedema—Paclitaxel—kidney cancer	0.00143	0.00143	CcSEcCtD
Cefoxitin—Hypotension—Gemcitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Cefoxitin—Abdominal pain—Dactinomycin—kidney cancer	0.00142	0.00142	CcSEcCtD
Cefoxitin—Body temperature increased—Dactinomycin—kidney cancer	0.00142	0.00142	CcSEcCtD
Cefoxitin—Leukopenia—Paclitaxel—kidney cancer	0.0014	0.0014	CcSEcCtD
Cefoxitin—Hypersensitivity—Sunitinib—kidney cancer	0.0014	0.0014	CcSEcCtD
Cefoxitin—Pruritus—Sorafenib—kidney cancer	0.00139	0.00139	CcSEcCtD
Cefoxitin—Vomiting—Erlotinib—kidney cancer	0.00139	0.00139	CcSEcCtD
Cefoxitin—Erythema multiforme—Capecitabine—kidney cancer	0.00139	0.00139	CcSEcCtD
Cefoxitin—Rash—Erlotinib—kidney cancer	0.00138	0.00138	CcSEcCtD
Cefoxitin—Dermatitis—Erlotinib—kidney cancer	0.00138	0.00138	CcSEcCtD
Cefoxitin—Pain—Vincristine—kidney cancer	0.00137	0.00137	CcSEcCtD
Cefoxitin—Flushing—Capecitabine—kidney cancer	0.00136	0.00136	CcSEcCtD
Cefoxitin—Dyspnoea—Gemcitabine—kidney cancer	0.00136	0.00136	CcSEcCtD
Cefoxitin—Nausea—Vinblastine—kidney cancer	0.00135	0.00135	CcSEcCtD
Cefoxitin—Convulsion—Paclitaxel—kidney cancer	0.00135	0.00135	CcSEcCtD
Cefoxitin—Nausea—Everolimus—kidney cancer	0.00135	0.00135	CcSEcCtD
Cefoxitin—Diarrhoea—Sorafenib—kidney cancer	0.00135	0.00135	CcSEcCtD
Cefoxitin—Pruritus—Sunitinib—kidney cancer	0.00134	0.00134	CcSEcCtD
Cefoxitin—Hypersensitivity—Dactinomycin—kidney cancer	0.00132	0.00132	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Vincristine—kidney cancer	0.00131	0.00131	CcSEcCtD
Cefoxitin—Pain—Gemcitabine—kidney cancer	0.0013	0.0013	CcSEcCtD
Cefoxitin—Nausea—Erlotinib—kidney cancer	0.0013	0.0013	CcSEcCtD
Cefoxitin—Diarrhoea—Sunitinib—kidney cancer	0.0013	0.0013	CcSEcCtD
Cefoxitin—Erythema—Capecitabine—kidney cancer	0.00128	0.00128	CcSEcCtD
Cefoxitin—Anaphylactic shock—Paclitaxel—kidney cancer	0.00127	0.00127	CcSEcCtD
Cefoxitin—Abdominal pain—Vincristine—kidney cancer	0.00127	0.00127	CcSEcCtD
Cefoxitin—Body temperature increased—Vincristine—kidney cancer	0.00127	0.00127	CcSEcCtD
Cefoxitin—Vomiting—Sorafenib—kidney cancer	0.00125	0.00125	CcSEcCtD
Cefoxitin—Thrombocytopenia—Paclitaxel—kidney cancer	0.00125	0.00125	CcSEcCtD
Cefoxitin—Rash—Sorafenib—kidney cancer	0.00124	0.00124	CcSEcCtD
Cefoxitin—Dermatitis—Sorafenib—kidney cancer	0.00124	0.00124	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00123	0.00123	CcSEcCtD
Cefoxitin—Diarrhoea—Dactinomycin—kidney cancer	0.00123	0.00123	CcSEcCtD
Cefoxitin—Vomiting—Sunitinib—kidney cancer	0.0012	0.0012	CcSEcCtD
Cefoxitin—Body temperature increased—Gemcitabine—kidney cancer	0.0012	0.0012	CcSEcCtD
Cefoxitin—Rash—Sunitinib—kidney cancer	0.00119	0.00119	CcSEcCtD
Cefoxitin—Dermatitis—Sunitinib—kidney cancer	0.00119	0.00119	CcSEcCtD
Cefoxitin—Hypotension—Paclitaxel—kidney cancer	0.00119	0.00119	CcSEcCtD
Cefoxitin—Anaemia—Capecitabine—kidney cancer	0.00118	0.00118	CcSEcCtD
Cefoxitin—Hypersensitivity—Vincristine—kidney cancer	0.00118	0.00118	CcSEcCtD
Cefoxitin—Eosinophilia—Doxorubicin—kidney cancer	0.00117	0.00117	CcSEcCtD
Cefoxitin—Nausea—Sorafenib—kidney cancer	0.00117	0.00117	CcSEcCtD
Cefoxitin—Leukopenia—Capecitabine—kidney cancer	0.00115	0.00115	CcSEcCtD
Cefoxitin—Vomiting—Dactinomycin—kidney cancer	0.00114	0.00114	CcSEcCtD
Cefoxitin—Dyspnoea—Paclitaxel—kidney cancer	0.00113	0.00113	CcSEcCtD
Cefoxitin—Rash—Dactinomycin—kidney cancer	0.00113	0.00113	CcSEcCtD
Cefoxitin—Nausea—Sunitinib—kidney cancer	0.00113	0.00113	CcSEcCtD
Cefoxitin—Pancytopenia—Doxorubicin—kidney cancer	0.00112	0.00112	CcSEcCtD
Cefoxitin—Neutropenia—Doxorubicin—kidney cancer	0.00111	0.00111	CcSEcCtD
Cefoxitin—Diarrhoea—Vincristine—kidney cancer	0.0011	0.0011	CcSEcCtD
Cefoxitin—Pain—Paclitaxel—kidney cancer	0.00109	0.00109	CcSEcCtD
Cefoxitin—Pruritus—Gemcitabine—kidney cancer	0.00108	0.00108	CcSEcCtD
Cefoxitin—Nausea—Dactinomycin—kidney cancer	0.00107	0.00107	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00105	0.00105	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00104	0.00104	CcSEcCtD
Cefoxitin—Diarrhoea—Gemcitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Cefoxitin—Jaundice—Doxorubicin—kidney cancer	0.00103	0.00103	CcSEcCtD
Cefoxitin—Thrombocytopenia—Capecitabine—kidney cancer	0.00102	0.00102	CcSEcCtD
Cefoxitin—Vomiting—Vincristine—kidney cancer	0.00102	0.00102	CcSEcCtD
Cefoxitin—Urticaria—Paclitaxel—kidney cancer	0.00101	0.00101	CcSEcCtD
Cefoxitin—Rash—Vincristine—kidney cancer	0.00101	0.00101	CcSEcCtD
Cefoxitin—Dermatitis—Vincristine—kidney cancer	0.00101	0.00101	CcSEcCtD
Cefoxitin—Abdominal pain—Paclitaxel—kidney cancer	0.00101	0.00101	CcSEcCtD
Cefoxitin—Body temperature increased—Paclitaxel—kidney cancer	0.00101	0.00101	CcSEcCtD
Cefoxitin—Agranulocytosis—Doxorubicin—kidney cancer	0.000985	0.000985	CcSEcCtD
Cefoxitin—Hypotension—Capecitabine—kidney cancer	0.000976	0.000976	CcSEcCtD
Cefoxitin—Vomiting—Gemcitabine—kidney cancer	0.000967	0.000967	CcSEcCtD
Cefoxitin—Rash—Gemcitabine—kidney cancer	0.000959	0.000959	CcSEcCtD
Cefoxitin—Dermatitis—Gemcitabine—kidney cancer	0.000958	0.000958	CcSEcCtD
Cefoxitin—Haemoglobin—Doxorubicin—kidney cancer	0.000953	0.000953	CcSEcCtD
Cefoxitin—Nausea—Vincristine—kidney cancer	0.000952	0.000952	CcSEcCtD
Cefoxitin—Haemorrhage—Doxorubicin—kidney cancer	0.000948	0.000948	CcSEcCtD
Cefoxitin—Hypersensitivity—Paclitaxel—kidney cancer	0.000938	0.000938	CcSEcCtD
Cefoxitin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000936	0.000936	CcSEcCtD
Cefoxitin—Dyspnoea—Capecitabine—kidney cancer	0.000931	0.000931	CcSEcCtD
Cefoxitin—Urethral disorder—Doxorubicin—kidney cancer	0.000929	0.000929	CcSEcCtD
Cefoxitin—Nausea—Gemcitabine—kidney cancer	0.000903	0.000903	CcSEcCtD
Cefoxitin—Pruritus—Paclitaxel—kidney cancer	0.000901	0.000901	CcSEcCtD
Cefoxitin—Erythema multiforme—Doxorubicin—kidney cancer	0.000896	0.000896	CcSEcCtD
Cefoxitin—Pain—Capecitabine—kidney cancer	0.000893	0.000893	CcSEcCtD
Cefoxitin—Flushing—Doxorubicin—kidney cancer	0.00088	0.00088	CcSEcCtD
Cefoxitin—Diarrhoea—Paclitaxel—kidney cancer	0.000871	0.000871	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000854	0.000854	CcSEcCtD
Cefoxitin—Urticaria—Capecitabine—kidney cancer	0.00083	0.00083	CcSEcCtD
Cefoxitin—Abdominal pain—Capecitabine—kidney cancer	0.000826	0.000826	CcSEcCtD
Cefoxitin—Body temperature increased—Capecitabine—kidney cancer	0.000826	0.000826	CcSEcCtD
Cefoxitin—Erythema—Doxorubicin—kidney cancer	0.000825	0.000825	CcSEcCtD
Cefoxitin—Vomiting—Paclitaxel—kidney cancer	0.000809	0.000809	CcSEcCtD
Cefoxitin—Rash—Paclitaxel—kidney cancer	0.000803	0.000803	CcSEcCtD
Cefoxitin—Dermatitis—Paclitaxel—kidney cancer	0.000802	0.000802	CcSEcCtD
Cefoxitin—Hypersensitivity—Capecitabine—kidney cancer	0.00077	0.00077	CcSEcCtD
Cefoxitin—Anaemia—Doxorubicin—kidney cancer	0.000763	0.000763	CcSEcCtD
Cefoxitin—Nausea—Paclitaxel—kidney cancer	0.000756	0.000756	CcSEcCtD
Cefoxitin—Pruritus—Capecitabine—kidney cancer	0.000739	0.000739	CcSEcCtD
Cefoxitin—Leukopenia—Doxorubicin—kidney cancer	0.000739	0.000739	CcSEcCtD
Cefoxitin—Convulsion—Doxorubicin—kidney cancer	0.000715	0.000715	CcSEcCtD
Cefoxitin—Diarrhoea—Capecitabine—kidney cancer	0.000715	0.000715	CcSEcCtD
Cefoxitin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000673	0.000673	CcSEcCtD
Cefoxitin—Vomiting—Capecitabine—kidney cancer	0.000664	0.000664	CcSEcCtD
Cefoxitin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000659	0.000659	CcSEcCtD
Cefoxitin—Rash—Capecitabine—kidney cancer	0.000659	0.000659	CcSEcCtD
Cefoxitin—Dermatitis—Capecitabine—kidney cancer	0.000658	0.000658	CcSEcCtD
Cefoxitin—Hypotension—Doxorubicin—kidney cancer	0.000629	0.000629	CcSEcCtD
Cefoxitin—Nausea—Capecitabine—kidney cancer	0.000621	0.000621	CcSEcCtD
Cefoxitin—Dyspnoea—Doxorubicin—kidney cancer	0.0006	0.0006	CcSEcCtD
Cefoxitin—Pain—Doxorubicin—kidney cancer	0.000576	0.000576	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000551	0.000551	CcSEcCtD
Cefoxitin—Urticaria—Doxorubicin—kidney cancer	0.000535	0.000535	CcSEcCtD
Cefoxitin—Abdominal pain—Doxorubicin—kidney cancer	0.000532	0.000532	CcSEcCtD
Cefoxitin—Body temperature increased—Doxorubicin—kidney cancer	0.000532	0.000532	CcSEcCtD
Cefoxitin—Hypersensitivity—Doxorubicin—kidney cancer	0.000496	0.000496	CcSEcCtD
Cefoxitin—Pruritus—Doxorubicin—kidney cancer	0.000476	0.000476	CcSEcCtD
Cefoxitin—Diarrhoea—Doxorubicin—kidney cancer	0.000461	0.000461	CcSEcCtD
Cefoxitin—Vomiting—Doxorubicin—kidney cancer	0.000428	0.000428	CcSEcCtD
Cefoxitin—Rash—Doxorubicin—kidney cancer	0.000425	0.000425	CcSEcCtD
Cefoxitin—Dermatitis—Doxorubicin—kidney cancer	0.000424	0.000424	CcSEcCtD
Cefoxitin—Nausea—Doxorubicin—kidney cancer	0.0004	0.0004	CcSEcCtD
